These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Ongoing||2004-001888-21||A cross-over comparative study of inhaled mannitol, alone and in combination with daily rhDNase, in children with cystic fibrosis||not-yet-due|
|Ongoing||2005-005452-41||A phase III Multicenter, randomised, parallel, placebo-controlled, double-blind study to investigate the safety and efficacy of treatment with Bronchitol (dry powder mannitol) in the symptomatic treat...||not-yet-due|
|Not reported Terminated||2006-004078-28||Long Term Administration of Inhaled Dry Powder Mannitol In Cystic Fibrosis – A Safety and Efficacy Study||2007-03-05||due-trials|
|Not reported||2007-001412-23||Long Term Administration of Inhaled Dry Powder Mannitol In Cystic Fibrosis – A Safety and Efficacy Study||2010-03-26||due-trials|
|Not reported Terminated||2008-002644-42||A phase III multicenter, randomized, parallel, controlled, double blind study to investigate the safety and efficacy of inhaled mannitol over 12 months in the treatment of bronchiectasis||2008-12-19||due-trials|
|Listed as ongoing, but also has a completion date||2008-002740-42||Long Term Administration of Inahled Mannitol in Cystic Fibrosis - A Safety and Efficacy Study||2010-10-25||bad-data|
|Exempt||2008-008228-34||Determination of the pharmacokinetics of inhaled mannitol after single and multiple dosing in cystic fibrosis patients||2009-12-08||not-yet-due|
|Listed as ongoing, but also has a completion date||2008-008731-28||A phase III multicenter, randomized, parallel, controlled, double blind study to investigate the safety and efficacy of inhaled mannitol over 12 months in the treatment of bronchiectasis.||2013-02-28||bad-data|
|Not reported Terminated||2011-000126-30||A phase II, multi-centre, single blind study to evaluate the safety, tolerability and explore the efficacy of 8.0 mg ASM8 inhaled daily for 14 days in adult subjects with moderate to severe asthma||2011-12-08||due-trials|
|Listed as ongoing, but also has a completion date||2012-002699-14||A randomised, multicentre, double-blind, placebo-controlled, crossover trial determining the efficacy of dry powder mannitol in improving lung function in subjects with Cystic Fibrosis aged six to sev...||2015-10-02||bad-data|
|Listed as ongoing, but also has a completion date||2013-005357-79||Long Term Administration of Inhaled Mannitol in Cystic Fibrosis – A Safety and Efficacy Trial in Adult Cystic Fibrosis Subjects||2017-02-21||bad-data|